. CLL cells exhibit concordant patterns of response to stimulation of TLR1/2, TLR2/6 and NOD2 with the appropriate ligands. From the pairs of CD25 and CD86 values for each stimulation experiment with Pam3CSK4, MALP-2 and MDP, the maximum value was selected as the representative value of responsiveness. Spearman correlation test revealed that (i) 53/58 cases (91%) showed qualitatively similar responses after TLR1/2 and TLR2/6 stimulation (p<0.001, R= 0.46); (ii) 50/57 (88%) and 52/57 (91%) cases responsive to NOD2 were also responsive to TLR1/2 and TLR2/6, respectively (p<0.05, R=0.26 and p<0.001, R=0.42); and, (iii) 46/65 (71%) cases had concordant patterns of response to stimulation of TLR1/2, TLR2/6 and NOD2 with their respective ligands (p<0.05). Pairwise scatter plots showing the distribution of the pairs of the new "max" variables indicate concordant patterns of response in independent stimulation of (A) TLR1/2 and TLR2/6; (B) TLR1/2 and NOD-2; (C) TLR2/6 and NOD-2; and, (D) all the above receptors.
. Distinct innate immunity responses in stereotyped CLL subsets are independent of mutational status. (A) Differences in CD25 and CD86 expression after stimulation of TLRs and NOD2 in M-CLL vs subset #4. (B) Differences in CLL cell viability after stimulation of TLRs and NOD2 in M-CLL vs subset #4. (C) Differences in CLL cell viability after stimulation of TLRs and NOD2 in U-CLL vs subset #1. Prior to statistical analysis values were normalized to the unstimulated controls. C: CpG ODN, P: Pam3CSK4, M: MALP-2, MD:MDP, I:Imiquimod, * p<0.05, ** p<0.005. Figure S3 . Differential responses to TLR and NOD2 stimulation in the 'minor' subsets of CLL cases with stereotyped BcRs, irrespective of IGHV gene mutational status. (A) Differences in CD25 and CD86 expression after stimulation of TLRs and NOD2 in M-CLL vs subset #16. (B) Differences in CD25 and CD86 expression after stimulation of TLRs and NOD2 in UM-CLL vs subset #8. (C) Comparison of unmutated subset #1 versus unmutated subset #8 revealed statistically significant differences in the induction of CD25 and CD86 after TLR1/2 stimulation with Pam3CSK4. (D) Comparison of mutated subset #4 vs mutated subset #16 revealed statistically significant differences in the induction of CD86 after TLR9 stimulation with CpG. The graphs are based on median values (before statistical analysis values were normalized to the unstimulated controls). C: CpG ODN, P: Pam3CSK4, M: MALP-2, MD:MDP, I:Imiquimod, * p<0.05. Supplementary Table S1 . Demographic, biological and clinical data of CLL patients included in the study. 
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